Pomdoctor Limited (POM)
| Market Cap | 8.42M |
| Revenue (ttm) | 57.18M +16.7% |
| Net Income | -30.39M |
| EPS | -9.42 |
| Shares Out | 7.46M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 141,368 |
| Open | 1.380 |
| Previous Close | 1.370 |
| Day's Range | 1.020 - 1.380 |
| 52-Week Range | 1.020 - 115.740 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | May 14, 2026 |
About POM
Pomdoctor Limited, through its subsidiaries, offers an online B2C portal to sell pharmaceutical products. The company develops an online medical services platform for chronic diseases in China. The company focuses on chronic disease management and pharmaceutical services and offers platform for medical services, which connects patients to doctors and pharmaceutical products. The company in involved in internet hospital and pharmaceutical supply chain, connecting users, pharmacies, suppliers, medical professionals, and other healthcare participa... [Read more]
Financial Performance
In 2025, Pomdoctor's revenue was 399.91 million, an increase of 16.74% compared to the previous year's 342.56 million. Losses were -212.58 million, 48.3% more than in 2024.
Financial numbers in CNY Financial StatementsNews
POMDOCTOR LIMITED Advances Healthcare Data Asset Strategy to Strengthen AI-Powered Chronic Disease Management Capabilities
GUANGZHOU, China, July 15, 2026 /PRNewswire/ -- POMDOCTOR LIMITED ("Pomdoctor" or the "Company") (NASDAQ: POM), a digital healthcare company focused on advancing AI-enabled healthcare solutions and pr...
PomDoctor regains Nasdaq compliance
PomDoctor (POM) announced that on July 10, the company received a letter from The Nasdaq Stock Market informing the company that it has regained compliance with the minimum bid price…
POMDOCTOR LIMITED Regains Compliance with Nasdaq Bid Price Requirement
GUANGZHOU, China, July 13, 2026 /PRNewswire/ -- POMDOCTOR LIMITED ("Pomdoctor" or the "Company") (NASDAQ: POM), a digital healthcare company focused on advancing AI-enabled healthcare solutions and pr...
PomDoctor continues efforts to advance chronic disease management ecosystem
PomDoctor (POM) highlighted its continued efforts in building an AI-powered chronic disease management ecosystem. The Company is integrating artificial intelligence, remote patient monitoring, wearabl...
POMDOCTOR LIMITED Continues to Advance AI-Enabled Chronic Disease Management Strategy Amid Growing Demand for Predictive Healthcare
GUANGZHOU, China, July 9, 2026 /PRNewswire/ -- POMDOCTOR LIMITED (the "Company") (NASDAQ: POM), a digital healthcare company focused on advancing AI-enabled healthcare solutions and predictive healthc...
POMDOCTOR LIMITED Announces Strategic Upgrade Toward Infrastructure for Predictive Healthcare Data and Services
GUANGZHOU, China, July 2, 2026 /PRNewswire/ -- POMDOCTOR LIMITED (the "Company") (NASDAQ: POM), a leading online medical services platform for chronic diseases in China, today announced a strategic up...
PomDoctor Ltd – ADR trading halted, news pending
19:50 EDT PomDoctor (POM) Ltd – ADR trading halted, news pending
POMDOCTOR LIMITED Announces ADS Ratio Change to Be Effective on June 22, 2026
GUANGZHOU, China, June 17, 2026 /PRNewswire/ -- POMDOCTOR LIMITED (the "Company") (NASDAQ: POM), a leading online medical services platform for chronic diseases in China, today announced that, as prev...
PomDoctor to implement ADS ratio change
PomDoctor (POM) plans to change the ratio of its American Depositary Shares, or ADSs, to its Class A ordinary shares from the current ratio of one ADS representing one-sixth Class…
POMDOCTOR LIMITED Announces Plan to Implement ADS Ratio Change
GUANGZHOU, China, May 28, 2026 /PRNewswire/ -- POMDOCTOR LIMITED (the "Company") (NASDAQ: POM), a leading online medical services platform for chronic diseases in China, today announced that it plans ...
POMDOCTOR LIMITED Announces Fiscal Year 2025 Financial Results
GUANGZHOU, China, May 14, 2026 /PRNewswire/ -- Pomdoctor Limited ("Pomdoctor" or the "Company") (NASDAQ: POM), a leading online medical services platform for chronic diseases in China, today announced...
POMDOCTOR LIMITED Announces Strategic Upgrade, Focusing on "AI + Medical-Grade Smart Wearables" to Build a New Ecosystem for Full-Cycle Chronic Disease Management
GUANGZHOU, China, March 13, 2026 /PRNewswire/ -- Pomdoctor Limited ("Pomdoctor" or the "Company") (NASDAQ: POM), a leading online medical services platform for chronic diseases in China, today announc...
POMDOCTOR LIMITED Expands Platform Integration With Online Medical Insurance Coverage Across Major Chinese Cities
GUANGZHOU, China, Feb. 4, 2026 /PRNewswire/ -- POMDOCTOR LIMITED ("Pomdoctor" or the "Company") (NASDAQ: POM), a leading online medical services platform for chronic diseases in China, today announced...
PomDoctor receives noncompliance notification from Nasdaq
PomDoctor (POM) announced that it has received a written notification from the staff of Nasdaq dated January 29, indicating that for the last 33 consecutive business days, the closing bid…
POMDOCTOR LIMITED Announces Receipt of Nasdaq Notice
GUANGZHOU, China, Feb. 2, 2026 /PRNewswire/ -- POMDOCTOR LIMITED ("Pomdoctor" or the "Company") (NASDAQ: POM), a leading online medical services platform for chronic diseases in China, today announced...
POMDOCTOR LIMITED Drive Internet Hospital Growth Through Strengthened Strategic Partnerships With Pharmaceutical Companies
GUANGZHOU, China, Jan. 16, 2026 /PRNewswire/ -- POMDOCTOR LIMITED ("Pomdoctor" or the "Company") (NASDAQ: POM), a leading online medical services platform for chronic diseases in China, today announce...
POMDOCTOR LIMITED Announces First Half of Fiscal 2025 Unaudited Financial Results
GUANGZHOU, China , Dec. 3, 2025 /PRNewswire/ -- Pomdoctor Limited ("Pomdoctor" or the "Company") (NASDAQ: POM), a leading online medical services platform for chronic diseases in China, today announce...
Citi Appointed as Depositary Bank for POMDOCTOR LIMITED's ADR Program
NEW YORK--(BUSINESS WIRE)--Citi Issuer Services, acting through Citibank, N.A., has been appointed by POMDOCTOR LIMITED (POM), a Chinese online medical services platform, as Depositary Bank for its Am...
POMDOCTOR LIMITED Announces Full Exercise and Closing of Underwriter's Over-Allotment Option
GUANGZHOU, China , Oct. 10, 2025 /PRNewswire/ -- POMDOCTOR LIMITED (Nasdaq: POM) (the "Company" or "POMDOCTOR"), a leading online medical services platform for chronic diseases in China, today announc...
POMDOCTOR LIMITED Announces Closing of Initial Public Offering
GUANGZHOU, China , Oct. 9, 2025 /PRNewswire/ -- POMDOCTOR LIMITED (Nasdaq: POM) (the "Company" or "POMDOCTOR"), a leading online medical services platform for chronic diseases in China, today announce...
PomDoctor 5M share IPO priced at $4.00
Joseph Stone Capital, LLC is acting as sole book running manager for the offering. The deal priced at low end of $4.00-$6.00 target range.
PomDoctor opens at $4.50, IPO priced at $4.00 per share
PomDoctor (POM), an online medical services platform for chronic diseases in China, priced 5M American Depositary Shares at $4.00 per ADS. Joseph Stone Capital is acting as sole book running…
POMDOCTOR LIMITED Announces Pricing of Initial Public Offering
GUANGZHOU, China , Oct. 8, 2025 /PRNewswire/ -- POMDOCTOR LIMITED (the "Company" or "POMDOCTOR"), a leading online medical services platform for chronic diseases in China, today announced the pricing ...
Chinese online medical platform PomDoctor files for a $15 million US IPO
PomDoctor, an online platform in China offering chronic disease management services, filed on Thursday with the SEC to raise up to $15 million in an initial public offering.
Pomdoctor IPO Registration Document (F-1)
Pomdoctor has filed to go public with an IPO on the NASDAQ.